Design and evaluation of bioadhesive in-situ nasal gel of ketorolac tromethamine

Chemical and Pharmaceutical Bulletin

Volumn 56, Issue 11, 2008, Pages 1596-1599

  Chelladurai, Sankar ^a   Mishra, Madhusmita ^a   Mishra, Brahmeshwar ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Bioadhesive; Chitosan; Gelling system; Ketorolac tromethamine; Nasal delivery; Pectin

Indexed keywords

ADHESIVE AGENT; CHITOSAN; HYDROXYPROPYLMETHYLCELLULOSE; KETOROLAC TROMETAMOL; PECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG STABILITY; FLOW KINETICS; GELATION; MALE; NONHUMAN; RAT; VISCOSITY;

ADHESIVENESS; ADHESIVES; ADMINISTRATION, INTRANASAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; CHEMISTRY, PHYSICAL; CHITOSAN; DRUG STABILITY; GELS; KETOROLAC TROMETHAMINE; MALE; NASAL MUCOSA; PECTINS; RATS; RATS, WISTAR; RHEOLOGY; SOLUBILITY;

EID: 55749087026     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.56.1596     Document Type: Article

References (22)

1. Ruel-Gariepy E., Leroux J. C., Eur. J. Pharm. Biopharm., 58, 409-426 (2004).
2. Miyazaki S., Suzuki S., Kawasaki N., Endo K., Takahashi A., Attwood D., Int. J. Pharm., 229, 29-36 (2001).
3. Srividya B., Cardoza R. M., Amin P. D., J. Controlled Release, 73, 205-211 (2001).
4. Liu L. S., Fishman M. L., Hicks K. B., Cellulose, 14, 15-24 (2007).
5. Illum L., Pharm. Res., 15, 1326-1331 (1998).
6. Balasubramanian J., Kant S., Pandit J. K., Acta Pharm., 53, 251-261 (2003).
7. Gilbert J. C., Richardson J. L., Davies M. C., Palin K. J., J. Controlled Release, 5, 113-118 (1987).
8. Nakamura F., Ohta R., Machida Y., Nagai T., Int. J. Pharm., 134, 173-181 (1996).
9. Mishra B., Panayam J., Sharma A. V., Acta Pharm. Turc., 41, 58-61 (1999).
10. Higuchi W. I., J. Pharm. Sci., 51, 802-804 (1962).
11. Winter C. A., Risley E. A., Nuss G. W., Proc. Soc. Exp. Biol., 111, 544-547 (1962).
12. Hirai S., Yashiki T., Mima H., Int. J. Pharm., 7, 317-325 (1981).
13. Hayama M., Medical Technol., 17, 543-547 (1989).
14. Kiessel T., Drewe J., Bantle S., Rummelt A., Belinger C., Pharm. Res., 9, 52-57 (1992).
15. Matthews B. R., Drug Dev. Ind. Pharm., 25, 831-856 (1999).
16. Ryu J. M., Chung S. J., Lee M. H., Kim C. K., Shim C. K., J. Controlled Release, 59, 163-172 (1999).
17. Jeong B., Lee K. M., Gutowska A., An Y. H., Biomacromolecules, 3, 865-868 (2002).
18. Park H., Amiji M., Park K., Proc. Int. Sym. Control. Rel. Bioact. Mater., 16, 217-218 (1989).
19. Johnson P. M., Rainsford K. D., Biochim. Biophys. Acta, 286, 72-78 (1972).
20. Peppas N. A., Buri P. A., J. Controlled Release, 2, 257-275 (1985).
21. Deasy P. B., Quigley K. J., Int. J. Pharm., 73, 117-123 (1991).
22. Kotze A. F., Luessen H. L., Thanou M., Verhoef J. C., de Boer A. G., Junginger H. E., Lehr C. M., "Chitosan and Chitosan Derivatives as Absorption Enhancers for Peptide Drugs across Mucosal Epithelia," Vol. 98, Chap. 31, ed. by Mathiowitz E., Chickering D. E. III, Lehr C. M., Marcel Dekker, New York, 1999, pp. 341-386.